BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

DOR BioPharma, Inc. 

1101 Brickell Avenue
Suite 701 South
Miami  Florida  33131  U.S.A.
Phone: 786-425-3848 Fax: 786-425-3853


SEARCH JOBS








 Company News
DOR BioPharma, Inc. (DORB) Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SGNX' 9/30/2009 10:40:23 AM    More...
DOR BioPharma, Inc. (DORB) Announces Private Equity Financing of $3.85 Million 9/24/2009 11:38:55 AM    More...
DOR BioPharma, Inc. (DORB) Announces National Institutes of Health (NIH) Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis 9/8/2009 8:42:34 AM    More...
DOR BioPharma, Inc. (DORB) Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments 8/14/2009 8:18:25 AM    More...
DOR BioPharma, Inc. (DORB) Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology 7/8/2009 10:34:45 AM    More...
DOR BioPharma, Inc. (DORB) Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller Company 7/7/2009 10:41:32 AM    More...
DOR BioPharma, Inc. (DORB) Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD 6/9/2009 10:13:51 AM    More...
DOR BioPharma, Inc. (DORB) Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 5/15/2009 10:38:08 AM    More...
DOR BioPharma, Inc. (DORB) Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments 3/31/2009 9:15:41 AM    More...
DOR BioPharma, Inc. (DORB) Executes $400,000 Equity Investment Agreement With Numoda Corporation 3/25/2009 10:35:40 AM    More...
12345678910...

//-->